ドラッグデリバリーデバイスの世界市場レポート 2024年

ドラッグデリバリーデバイスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.6%の年間複合成長率（CAGR）で1,220億7,000万米ドルに成長すると予想されます。今後の期間に予想される拡大は、慢性疾患の有病率の上昇、注射剤の需要の増大、ドラッグデリバリーデバイスの必要性の増大、と重度の感染症の突然の出現によるものと考えられます。予測期間に予想される主要な動向には、ドラッグデリバリーのためのマイクロニードル医薬品技術への投資、自己注射なドラッグデリバリーデバイスの研究開発、合併と買収への焦点、とウェアラブルドラッグデリバリーデバイスへの投資が含まれます。

心血管疾患、糖尿病、がん、その他の疾患などの慢性疾患の有病率の増加により、ドラッグデリバリーデバイス市場が推進されると予想されます。たとえば、2023年 1月の国立医学図書館によると、少なくとも1つの慢性疾患を患う米国の50歳以上の人の数は99.5%増加し、2050年までに1億4,266万人に達すると予測されています。 薬物投与にはさまざまな経路が存在し、その選択は、求める効果、疾患の種類、製品タイプの3つの要素によって決まります。製薬業界は現在、慢性疾患の有病率の上昇により世界中で研究開発努力が増加しており、新しいドラッグデリバリーシステムの開発に重点を置いています。多くの製薬会社は、自社製品の利点を強化し、成果を向上させるために、複数のドラッグデリバリー技術に注力しています。したがって、慢性疾患の有病率の増加は治療薬や療法の消費量の増加につながり、ドラッグデリバリーデバイス市場の成長の原動力となっています。

生物製剤の需要の増加は、ドラッグデリバリーデバイス市場の拡大に寄与すると予想されます。生物製剤は、生物製剤または生物医薬品としても知られ、生きた有機体、細胞、または生物学的プロセスを使用して開発された医薬品です。 ドラッグデリバリーデバイスは、送達方法の改善、非侵襲的送達の提供、貨物の保護、放出制御の提供、標的送達の可能化、高度なドラッグデリバリーシステムの提供により、生物製剤の送達を強化する上で重要な役割を果たします。 2023年6月、カナダ政府によると、カナダは2021年の一人当たり支出額で経済協力開発機構（OECD）の上位国にランクされ、生物製剤の売上高は110億米ドルを超えました。したがって、生物製剤に対する需要の増加は、ドラッグデリバリーデバイス市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のドラッグデリバリーデバイス市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のドラッグデリバリーデバイスの市場規模実績と成長、2018～2023年
• 世界のドラッグデリバリーデバイス市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のドラッグデリバリーデバイス市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 経口ドラッグデリバリー
• 注射ドラッグデリバリー
• 局所ドラッグデリバリー
• 経眼ドラッグデリバリー
• 経肺ドラッグデリバリー
• 経鼻薬ドラッグデリバリー
• 経粘膜ドラッグデリバリー
• 埋込ドラッグデリバリー
• 世界のドラッグデリバリーデバイス市場、患者ケア場所別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 診断センター
• 外来手術センター/クリニック
• 在宅医療
• その他
• 世界のドラッグデリバリーデバイス市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• がん
• 感染症
• 呼吸器疾患
• 糖尿病
• 心血管疾患
• 自己免疫疾患
• 中枢神経系疾患
• その他

第7章 地域と国の分析

• 世界のドラッグデリバリーデバイス市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のドラッグデリバリーデバイス市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドラッグデリバリーデバイス市場の競合情勢
• ドラッグデリバリーデバイス市場の企業プロファイル
  • Becton, Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG
  • Catalent
  • 3M Company

第31章 その他の大手と革新的な企業

• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• Smiths Medical
• Boehringer Ingelheim
• SMC Ltd.
• Elcam Medical
• Eli Lilly and Company
• Gerresheimer
• Injex
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc
• Sanofi Sa
• Schott AG
• Terumo Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Drug delivery devices are designed to administer specific drugs to targeted areas of the body for disease treatment. These devices find application in various patient care environments, including hospitals, diagnostic centers, clinics, and home care settings.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

The drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market size has grown strongly in recent years. It will grow from $87.65 billion in 2023 to $94.7 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The expansion observed in the past can be credited to the swift increase in the elderly population, a rise in the number of healthcare facilities, economic growth in emerging markets, and an augmentation in healthcare expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $122.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated expansion in the upcoming period can be ascribed to the rising prevalence of chronic diseases, growing demand for injectables, an increasing need for drug delivery devices, and the sudden emergence of severe infections. Key trends expected in the forecast period involve investments in microneedle drug technology for drug delivery, the research and development of self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices.

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and other conditions is expected to propel the drug delivery devices market. For example, in January 2023, according to the National Library of Medicine, the number of individuals in the United States aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Various routes of drug administration exist, and the choice depends on three factors, the desired effect, the type of disease, and the product type. The pharmaceutical industry is currently emphasizing the development of new drug delivery systems, driven by increasing R&D efforts worldwide due to the rising prevalence of chronic diseases. Many pharmaceutical companies are concentrating on multiple drug delivery technologies to enhance advantages and improve outcomes for their products. Therefore, the growing prevalence of chronic diseases is leading to increased consumption of therapeutic drugs and therapies, acting as a driver for the drug delivery devices market's growth.

The increasing demand for biologics is expected to contribute to the expansion of the drug delivery device market. Biologics, also known as biologic products or biopharmaceuticals, are pharmaceuticals developed using living organisms, cells, or biological processes. Drug delivery devices play a crucial role in enhancing biologics delivery by improving delivery methods, providing non-invasive delivery, protecting cargo, offering controlled release, enabling targeted delivery, and providing advanced drug delivery systems. In June 2023, according to the Government of Canada, Canada ranked among the top nations in the Organization for Economic Co-operation and Development (OECD) in terms of per capita spending in 2021, with biologics sales exceeding $11 billion. Hence, the increasing demand for biologics is a driving force for the growth of the drug delivery device market.

Leading companies in the drug delivery device market are strategically focusing on the development of innovative devices, such as autoinjectors with fully integrated connectivity, to gain a competitive advantage. Autoinjectors are specialized medical devices designed for self-administration of pre-measured medication doses. For example, in December 2021, Ypsomed AG, a Switzerland-based manufacturer of injection and infusion equipment, introduced YpsoMate, an autoinjector featuring fully integrated connectivity. The device is equipped with standard built-in Bluetooth communication, enabling connectivity to mobile phones and tablets for the transfer of injection and device data. This autoinjector provides digital therapy support by automatically recording medication administrations and sharing data with healthcare providers.

Microneedle (MN) technology is recognized for its efficiency and versatility in the medical device landscape, boasting attributes such as painless penetration, cost-effectiveness, high therapeutic efficacy, and relative safety. Key players in the global microneedle drug delivery system market include 3M, Vetter Pharma International GmbH, Nano Biosciences LLC, Nano Pass, and others. Microneedles are crafted using biodegradable polymers that encapsulate drugs or vaccines. Upon dissolution in the skin, the microneedles release the drug. This innovative delivery method facilitates the passage of a diverse range of molecules through the skin barrier, allowing transdermal delivery for various clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aligns with Sandoz's strategic goal of expanding its current respiratory medication portfolio and enhancing patient access to advanced treatments. Coalesce Product Development Limited, based in the UK, specializes in the manufacturing of respiratory medical and medication delivery devices.

Major companies operating in the drug delivery devices market report are Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Gerresheimer, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, West Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc., Covidien plc

North America was the largest region in the drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Tapered Implants; Parallel Walled Implants
• 2) By Material: Titanium; Zirconium; Other Materials
• 3) By End-Use: Hospitals; Dental Clinics; Other End Uses
• Companies Mentioned: Becton, Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; 3M Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Delivery Devices Market Characteristics

3. Drug Delivery Devices Market Trends And Strategies

4. Drug Delivery Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Drug Delivery Devices Market Size and Growth

• 5.1. Global Drug Delivery Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Delivery Devices Market Segmentation

• 6.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Implantable Drug Delivery
• 6.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Other Patient Care Settings
• 6.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cancer
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Other Applications

7. Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Delivery Devices Market

• 8.1. Asia-Pacific Drug Delivery Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Delivery Devices Market

• 9.1. China Drug Delivery Devices Market Overview
• 9.2. China Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Delivery Devices Market

• 10.1. India Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Delivery Devices Market

• 11.1. Japan Drug Delivery Devices Market Overview
• 11.2. Japan Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Delivery Devices Market

• 12.1. Australia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Delivery Devices Market

• 13.1. Indonesia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Delivery Devices Market

• 14.1. South Korea Drug Delivery Devices Market Overview
• 14.2. South Korea Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Delivery Devices Market

• 15.1. Western Europe Drug Delivery Devices Market Overview
• 15.2. Western Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Delivery Devices Market

• 16.1. UK Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Delivery Devices Market

• 17.1. Germany Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Delivery Devices Market

• 18.1. France Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Delivery Devices Market

• 19.1. Italy Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Delivery Devices Market

• 20.1. Spain Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Delivery Devices Market

• 21.1. Eastern Europe Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Delivery Devices Market

• 22.1. Russia Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Delivery Devices Market

• 23.1. North America Drug Delivery Devices Market Overview
• 23.2. North America Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Delivery Devices Market

• 24.1. USA Drug Delivery Devices Market Overview
• 24.2. USA Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Delivery Devices Market

• 25.1. Canada Drug Delivery Devices Market Overview
• 25.2. Canada Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Delivery Devices Market

• 26.1. South America Drug Delivery Devices Market Overview
• 26.2. South America Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Delivery Devices Market

• 27.1. Brazil Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Delivery Devices Market

• 28.1. Middle East Drug Delivery Devices Market Overview
• 28.2. Middle East Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Delivery Devices Market

• 29.1. Africa Drug Delivery Devices Market Overview
• 29.2. Africa Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Drug Delivery Devices Market Competitive Landscape
• 30.2. Drug Delivery Devices Market Company Profiles
  • 30.2.1. Becton, Dickinson and Company
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Baxter International
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. B. Braun Melsungen AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Catalent
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. 3M Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. West Pharmaceutical Services, Inc.
• 31.2. Gerresheimer AG
• 31.3. Smiths Medical
• 31.4. Boehringer Ingelheim
• 31.5. SMC Ltd.
• 31.6. Elcam Medical
• 31.7. Eli Lilly and Company
• 31.8. Gerresheimer
• 31.9. Injex
• 31.10. Novartis AG
• 31.11. Novo Nordisk A/S
• 31.12. Pfizer Inc
• 31.13. Sanofi Sa
• 31.14. Schott AG
• 31.15. Terumo Corporation

32. Global Drug Delivery Devices Market Competitive Benchmarking

33. Global Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Delivery Devices Market

35. Drug Delivery Devices Market Future Outlook and Potential Analysis

• 35.1 Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Drug Delivery Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer